BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10488328)

  • 1. [The therapy of acute myeloid leukemia in patients of advanced age].
    Kern W; Schoch C; Fonatsch C; Heinecke A; Wörmann B; Büchner T; Hiddemann W
    Dtsch Med Wochenschr; 1999 Aug; 124(34-35):1005-14. PubMed ID: 10488328
    [No Abstract]   [Full Text] [Related]  

  • 2. The approach to the elderly patient with acute myeloid leukemia.
    Stone RM; Mayer RJ
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):65-79. PubMed ID: 7680642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of survival. Chemotherapeutically treated and untreated older patient with acute myeloid leukemia.
    Siddiqui T; Durkin WJ; Conley NS; Doughney KB; Favis GR; Weiss R; Smith AE
    J Fla Med Assoc; 1994 Jul; 81(7):475-7. PubMed ID: 7964574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostics and therapy of acute myeloid leukemia].
    Fritsch S; Metzeler K; Hiddemann W; Buske C
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2401-6. PubMed ID: 17054056
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute leukemia: which of two types of cell death (necrosis or apoptosis) may be responsible for patients' death during intensive chemotherapy?].
    Petukhov VI; Pavlov BN
    Ter Arkh; 2002; 74(12):100-4. PubMed ID: 12577856
    [No Abstract]   [Full Text] [Related]  

  • 6. The outcome of intensive induction therapy in patients >or=70 years with acute myeloid leukemia.
    Gupta V; Xu W; Keng C; Alibhai SM; Brandwein J; Schimmer A; Schuh A; Yee K; Minden MD
    Leukemia; 2007 Jun; 21(6):1321-4. PubMed ID: 17344911
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
    Stone RM; Mayer RJ
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):47-64. PubMed ID: 8449864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elderly patients with acute myeloid leukemia: characteristics in biology, patients, and treatment].
    Wedding U; Bokemeyer C; Meran JG; ; ;
    Med Klin (Munich); 2003 Apr; 98(4):193-207. PubMed ID: 12715143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy.
    Doubek M; Palasek I; Brychtova Y; Buchtova I; Mayer J
    Neoplasma; 2005; 52(5):411-4. PubMed ID: 16151586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The current chemotherapy of acute myeloid leukemias in adults].
    Poddubnaia IV; Perilov AA
    Ter Arkh; 1993; 65(7):86-9. PubMed ID: 8211791
    [No Abstract]   [Full Text] [Related]  

  • 11. Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.
    Venugopal P; Manson S; Preisler HD
    Cancer Treat Res; 2001; 108():257-65. PubMed ID: 11702603
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective study.
    Behringer B; Pitako JA; Kunzmann R; Schmoor C; Behringer D; Mertelsmann R; Lübbert M
    Ann Hematol; 2003 Jul; 82(7):381-9. PubMed ID: 12756497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "3+7" therapy for the treatment of acute myeloid leukemia. CON.
    Estey EH
    Clin Adv Hematol Oncol; 2005 Feb; 3(2):129-132, 141. PubMed ID: 16173152
    [No Abstract]   [Full Text] [Related]  

  • 14. New agents in the treatment of acute myeloid leukemia.
    Wiernik PH
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):95-8. PubMed ID: 1780763
    [No Abstract]   [Full Text] [Related]  

  • 15. [The therapeutic results in acute myeloid leukemias in elderly patients].
    Parovichnikova EN; Savchenko VG; Isaev VG; Tikhonova LIu; Sarycheva TG; Kulikov SM
    Ter Arkh; 1992; 64(8):87-9. PubMed ID: 1440406
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies other than dose-intensification should be pursued in elderly patients with untreated acute myeloblastic leukemia.
    Haematologica; 2002 Aug; 87(8):786. PubMed ID: 12161350
    [No Abstract]   [Full Text] [Related]  

  • 17. Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression.
    Junghanss C; Waak M; Knopp A; Kleine HD; Kundt G; Leithäuser M; Hilgendorf I; Wolff D; Casper J; Freund M
    Neoplasma; 2005; 52(5):402-10. PubMed ID: 16151585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
    Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of acute myeloid leukemia in children.
    Nesbit ME; Woods WG
    Leukemia; 1992; 6 Suppl 2():31-5. PubMed ID: 1578938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia.
    Baz R; Rodriguez C; Fu AZ; Jawde RA; Kalaycio M; Advani A; Sobecks R; Sekeres MA
    Cancer; 2007 Oct; 110(8):1752-9. PubMed ID: 17724726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.